By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pfizer will collaborate with Medco Health Solutions and its United BioSource subsidiary in a research effort based on Pfizer's "precision medicine" approach, which integrates genomic and phenotypic information to help identify patients that may benefit from a new drug.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.

Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.

In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.

Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.